BioSpace News Archive

Drug Development

Daiichi Sankyo Initiates Pivotal Phase 3 Trial of [Fam-] Trastuzumab Deruxtecan (DS-8201) in HER2 Low Metastatic Breast Cancer

Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced that the first patient has been dosed in DESTINY-Breast04, a global pivotal phase 3 study evaluating the safety and efficacy of [fam-] trastuzumab deruxtecan (DS-8201),

January 14, 2019
·
8 min read
Business

Warrior and Spouse Vow Peace, Protection, and Prosperity During Couples Project Odyssey

Adding another level of complexity, Sidney copes with post-traumatic stress disorder stemming from his deployment during Operation Enduring Freedom.

January 14, 2019
·
2 min read
Policy

Massachusetts Mesothelioma Victims Center Now Offers a Construction Worker with Mesothelioma or Asbestos Lung Cancer in Massachusetts Direct Access to Famed Mesothelioma Attorney Erik Karst for Vital Tips About Compensation

The Massachusetts Mesothelioma Victims Center says, “We are urging a construction worker or a skilled tradesman such an electrician, plumber, welder or machinist in Massachusetts who has recently been diagnosed with mesothelioma or asbestos exposure lung cancer to call us anytime at 800-714-0303 to ensure they are talking directly with Erik Karst the founding partner of the law firm Karst von Oiste.

January 14, 2019
·
3 min read
Bio NC

Premier Inc. Announces Expanded Effort to Supply Shortage Generic Drugs

Goal is to permanently address drug shortage problem, ensuring continuous access to life-saving products at an affordable price

January 14, 2019
·
5 min read
Business

Caliva Partners with Best-In-Class Emulsion Technology Provider

Caliva, The Most Trusted Brand in Cannabis, has partnered with the world’s leading nano-emulsion technology provider, Tarukino, to bring premium beverages to the California market.

January 14, 2019
·
2 min read
FDA

FDA Approves World’s First Device for Treatment of Premature Babies and Newborns with an Opening in Their Hearts (a Common Congenital Defect)

Abbott (NYSE: ABT) today announced the U.S. Food and Drug Administration (FDA) approved the Amplatzer Piccolo™ Occluder, the world’s first medical device that can be implanted in the tiniest babies (weighing as little as two pounds) using a minimally invasive procedure to treat patent ductus arteriosus, or PDA.

January 14, 2019
·
6 min read
BioMidwest

Payformance Solutions Named One of Chicago’s Best Places to Work

Health tech startup wins recognition in Built In Chicago’s 2019 Best Places to Work Awards in the Small Companies category

January 14, 2019
·
2 min read
Biotech Bay

Casa Madrona Hotel & Spa Completes Multi-Million-Dollar Wellness Renovation

Overlooking Sausalito’s boat-filled harbor on Richardson’s Bay, Casa Madrona Hotel & Spa is welcoming the year by unveiling a multi-million-dollar renovation with a focus on the lobby and a new Wellness Experience which debuted on January 11.

January 14, 2019
·
5 min read
Business

Voice of the Patient: Can You Hear Me Now?

Ken Sakal CEO of Vohesu to present at 2019 Alexa Conference

January 14, 2019
·
1 min read
Biotech Beach

Anthem Blue Cross Collaborates with CVS Pharmacy to Increase Access to Health Products

Anthem Blue Cross (Anthem) announced today that, beginning January 2019, consumers enrolled in its Medicare Advantage health plans will be able to purchase over-the-counter (OTC) medications and health-related products at CVS Pharmacy stores using their health plan’s allowance

January 14, 2019
·
3 min read